DRUG · Mapped RxNorm record
Trastuzumab
Normalized identity: trastuzumabView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer
NCT00427427
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedDelayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
TrastuzumabDRUG · verified · RxNorm: trastuzumab
Sponsors & collaborators
Jonsson Comprehensive Cancer Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00427427 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.